Arrakis Bio
Arrakis Bio

Arrakis Bio

Measured by AhrefsDR2Ahrefs DR: 2/100. Bottom 25%. Measured by Ahrefs. Median 44.Measured by StartupHub.aiAgent43Agent Readiness: 43/100. Above median. Measured by StartupHub.ai. Median 41.Measured by Google PageSpeedSpeed46Site Speed: 46/100. Bottom 25%. Measured by Google PageSpeed. Median 62.Measured by StartupHub.aiTrust78Data Trust: 78/100. Above median. Measured by StartupHub.ai. Median 61.

Arrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform.

2019Active5Cambridge, United States

About

Arrakis Bio bio-manufactures regenerative human biomaterials, starting with medical-grade human collagen. Their proprietary technology enables sustainable, scalable production of high-purity collagen for medical aesthetics, regenerative medicine, and biomedical research. Arrakis Bio aims to revolutionize the availability of these advanced biomaterials for a healthier and more beautiful future.

Key facts

Website
arrakis.bio
Headquarters
Cambridge, United States
Founded
2019
Employees
5
Business model
B2B

Tech stack

Detected on arrakis.bio, last scanned 22 Oct 2026.

Observability
Sentry
CMS / Builders
Wix
CDN
Cloudflare
Email provider
Microsoft 365

Arrakis Bio scores 2. Does yours?

That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.

Add first review

Frequently asked

Is Arrakis Bio trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Arrakis Bio is 78 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

How many employees does Arrakis Bio have?

Arrakis Bio has approximately 5 people on record.

Public record

SEC filings, insider activity, nonprofit links and pay benchmarks for Arrakis Bio